Increasing Colorectal Cancer Screening in a Safety-net Health System With a Focus on the Uninsured: Benefits and Costs
Colorectal Cancer
About this trial
This is an interventional health services research trial for Colorectal Cancer focused on measuring colorectal neoplasms, screening
Eligibility Criteria
Inclusion Criteria:
- 54 to 64 year old men and women
- All races and ethnicities
- Patients that have been on JPS Connection in 2010 or JPS Connection in 2009 and have been seen at least once between September 1, 2009 and August 31, 2010 in any JPS setting
Exclusion Criteria:
- No address and phone number on file
- Incarcerated individuals
- Primary language other than English or Spanish
Up to date with CRC screening, defined as any:
- Fecal Occult Blood Test (FOBT) in 2009
- Flexible Sigmoidoscopy 2005-09
- Barium Enema 2005-09
- Colonoscopy 2002-09* Prior history of CRC, inflammatory bowel disease, or colorectal polyps.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
Mailed invitations for FIT test kits
Mailed invitations for a colonoscopy
Visit Based Care
Fecal Immunochemical Tests (FIT) kits from Polymedco Incorporated are mailed to patients' homes for free colorectal cancer screening. Intervention: Screening for colorectal cancer using a Polymedco home FIT kit. Mailed invitation to complete a free one sample home FIT kit. Automated and live phone call reminders to promote screening completion, plus usual medical care. Patients with abnormal FIT results are navigated to complete a diagnostic colonoscopy.
Invitation to schedule a colonoscopy are mailed to patients' homes for free colorectal cancer screening. Intervention: Screening for colorectal cancer with colonoscopy. Mailed invitation to complete one free colonoscopy. Automated and live phone reminders to promote screening completion, plus usual medical care. Patients with abnormal polyps or adenomas will follow standard clinical protocol after their procedure.
No invitation to complete colorectal cancer screening. Intervention: Usual medical care. Patients will continue to see their regular physician, and follow their physician's regular standard of care.